Experiences with
Bevacizumab98 public posts
Want to take advantage of all our features? Just log in!
or
Webinar: New approved treatment for wet AMD
Lytenava (bevacizumab gamma), is the first licensed version of Avastin for wet age-related macular degeneration. The treatment was approved by the National Institute for Health and Care Excellence (NICE) for use in the NHS last year.
Good news from the ATTLAS trial for patients with EGFR mutations and ALK translocations.
Treatment with atezolizumab, bevacizumab, paclitaxel, and carboplatin (ABCP) was significantly more effective than pemetrexed plus carboplatin or cisplatin
https://dailynews.ascopubs.org/do/atezolizumab-bevacizumab-and-chemotherapy-improves-pfs-egfr---alk--mutated-nsclc-after?